Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, TX (A.P., M.N., T.F., A.D.-W., A.L., C.T., P.A.S., A.D., M.V.).
International Arrhythmia Center, Fundación Cardioinfantil, Bogotá, Colombia (D.R., L.C.S.).
Circ Arrhythm Electrophysiol. 2022 Aug;15(8):e011017. doi: 10.1161/CIRCEP.122.011017. Epub 2022 Aug 2.
Coronary venous ethanol ablation (VEA) can be used as a strategy to treat ventricular arrhythmias arising from the left ventricular summit, but collateral flow and technical challenges cannulating intramural veins in complex venous anatomies can limit its use. Advanced techniques for VEA can capitalize on collateral vessels between target and nontarget sites to improve success.
Of 55 patients with left ventricular summit ventricular arrhythmia, advanced techniques were used in 15 after initial left ventricular summit intramural vein mapping failed to show suitable targets for single vein, single-balloon VEA. All patients had previous radiofrequency ablation attempts. Techniques included: double-balloon for distal protection to block distal flow and target the proximal portion of a large intramural vein where best signal was proximal (n=6); balloons in 2 different left ventricular summit veins for a cross-fire multivein VEA (n=4); intramural collateral vein-to-vein cannulation to reach of targeted vein via collateral with antegrade ethanol and proximal balloon block (n=2); prolonged ethanol dwell time for vein sclerosis of large intramural vein and subsequent VEA (n=3); and intramural collateral VEA (n=1).
Fifteen (8 females) patients (age 60.6±17.6 years) required advanced techniques. Procedure time was 210±49.9 minutes, fluoroscopy time was 25.3±14.1 minutes, and 113±17.9 cc of contrast was utilized. A median of 7 cc of ethanol was delivered (range, 4-15 cc). Intraprocedural radiofrequency ablation was delivered before ethanol in 9 out of 15 patients but failed. Ethanol achieved acute success in all 15 patients. Ethanol was used as the sole treatment in two patients. At a median follow-up of 194 days, one patient experienced recurrence.
Advanced techniques capitalizing on venous anatomy can enable successful VEA and selective targeting of arrhythmogenic sites, by blocking distal flow, utilization of collaterals between nontarget and target veins and multivein VEA. Understanding individual anatomy is critical for VEA success.
冠状静脉乙醇消融(VEA)可用作治疗源自左心室顶点的室性心律失常的策略,但侧支血流和在复杂静脉解剖结构中进行心室内静脉插管的技术挑战可能会限制其使用。VEA 的先进技术可以利用目标和非目标部位之间的侧支血管来提高成功率。
在 55 例左心室顶点室性心律失常患者中,15 例在初始左心室顶点心室内静脉标测显示单个静脉、单个球囊 VEA 不适合的情况下,采用先进技术。所有患者均有射频消融尝试史。技术包括:双球囊用于远端保护,以阻断远端血流并将目标对准信号最好的近端大心室内静脉(n=6);2 个不同的左心室顶点静脉中的球囊用于交叉射击多静脉 VEA(n=4);心室内侧支静脉-静脉插管,通过侧支用顺行乙醇和近端球囊阻断到达目标静脉(n=2);延长大心室内静脉的乙醇停留时间,以静脉硬化,随后进行 VEA(n=3);以及心室内侧支 VEA(n=1)。
15 例(8 例女性)患者(年龄 60.6±17.6 岁)需要采用先进技术。手术时间为 210±49.9 分钟,透视时间为 25.3±14.1 分钟,使用 113±17.9cc 造影剂。中位数为 7cc 乙醇(范围 4-15cc)。15 例患者中有 9 例在乙醇前进行了腔内射频消融,但均未成功。所有 15 例患者均在乙醇治疗后获得即刻成功。2 例患者仅使用乙醇治疗。在中位数为 194 天的随访中,1 例患者复发。
通过阻断远端血流、利用非目标和目标静脉之间的侧支以及多静脉 VEA,利用静脉解剖结构的先进技术可以实现成功的 VEA 和对心律失常部位的选择性靶向。了解个体解剖结构对 VEA 成功至关重要。